Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nitrous Oxide for the Management of Labor Pain [Internet].
Likis FE, Andrews JC, Collins MR, Lewis RM, Seroogy JJ, Starr SA, Walden RR, McPheeters ML. Likis FE, et al. Among authors: seroogy jj. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Aug. Report No.: 12-EHC071-EF. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Aug. Report No.: 12-EHC071-EF. PMID: 23016161 Free Books & Documents. Review.
Traumatic Brain Injury and Depression [Internet].
Guillamondegui OD, Montgomery SA, Phibbs FT, McPheeters ML, Alexander PT, Jerome RN, McKoy JN, Seroogy JJ, Eicken JJ, Krishnaswami S, Salomon RM, Hartmann KE. Guillamondegui OD, et al. Among authors: seroogy jj. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Apr. Report No.: 11-EHC017-EF. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Apr. Report No.: 11-EHC017-EF. PMID: 21938798 Free Books & Documents. Review.
Nitrous oxide for the management of labor pain: a systematic review.
Likis FE, Andrews JC, Collins MR, Lewis RM, Seroogy JJ, Starr SA, Walden RR, McPheeters ML. Likis FE, et al. Among authors: seroogy jj. Anesth Analg. 2014 Jan;118(1):153-67. doi: 10.1213/ANE.0b013e3182a7f73c. Anesth Analg. 2014. PMID: 24356165 Review.
Phase I dose-escalation and pharmacokinetic study of ispinesib, a kinesin spindle protein inhibitor, administered on days 1 and 15 of a 28-day schedule in patients with no prior treatment for advanced breast cancer.
Gomez HL, Philco M, Pimentel P, Kiyan M, Monsalvo ML, Conlan MG, Saikali KG, Chen MM, Seroogy JJ, Wolff AA, Escandon RD. Gomez HL, et al. Among authors: seroogy jj. Anticancer Drugs. 2012 Mar;23(3):335-41. doi: 10.1097/CAD.0b013e32834e74d6. Anticancer Drugs. 2012. PMID: 22123335 Clinical Trial.